Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Cladribine (subcutaneous use)

EU orphan designation number: EU/3/01/055
Active ingredient: Cladribine (subcutaneous use)
Indication: Treatment of indolent non-Hodgkin's lymphoma
Sponsor: Lipomed GmbH
Hegenheimer Straße 2, 79576 Weil/Rhein, Deutschland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Litak on 14/04/2004 with the number EU/1/04/275

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/09/2001 Orphan designation EMEA/OD/006/01 (2001)2718 of 18/09/2001
05/11/2010 Change of name and/or address of sponsor EMA/501271/2010
19/04/2014 Removal of orphan designation from Community Register